The results of our study confirm that the changes in the glycosylation level of fibrinogen were highly significant, with haptoglobin, serotransferrin, and, to some degree, hemopexin, also useful in the differentiation of LC patients from control subjects. This evidence concerns the gene HPX and laryngotracheoesophageal cleft.